0001567619-20-012731.txt : 20200630 0001567619-20-012731.hdr.sgml : 20200630 20200630214818 ACCESSION NUMBER: 0001567619-20-012731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200430 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mueller Brian CENTRAL INDEX KEY: 0001514980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 201003867 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2020-04-30 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001514980 Mueller Brian 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2020-04-30 5 A 0 323 62.586 A 25104 D Common Stock 2020-06-29 4 A 0 4640 0 A 29744 D Stock Option (Right to buy Common Stock) 122.18 2020-06-29 4 A 0 13230 0 A 2021-06-29 2030-06-28 Common Stock 13230 13230 D Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan. Restricted stock units granted on June 29, 2020. Price not applicable. Option grant vests 12/48th on June 29, 2021 and 1/48th on the 29th day of each month thereafter. /s/ Eric Fleekop, Attorney-in-Fact 2020-06-30